Transcriptome analysis of Burkitt lymphoma cells treated with anti-convulsant drugs that are inhibitors of Epstein-Barr virus lytic reactivation.
Herpesviruses have two distinct life cycle stages, latency and lytic replication. Epstein-Barr virus (EBV), a gamma-herpesvirus, establishes latency in vivo and in cultured cells. Cell lines harboring latent EBV can be induced into the lytic cycle by treatment with chemical inducing agents. In the B...
Päätekijät: | Kelly L Gorres, David M Reineke, George Miller |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Public Library of Science (PLoS)
2024-01-01
|
Sarja: | PLoS ONE |
Linkit: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0299198&type=printable |
Samankaltaisia teoksia
-
Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
Tekijä: Kelly L. Gorres, et al.
Julkaistu: (2016-05-01) -
Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
Tekijä: Abbie G. Anderson, et al.
Julkaistu: (2019-05-01) -
Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus
Tekijä: Rebecca L. Hutcheson, et al.
Julkaistu: (2021-01-01) -
Identification of Epstein-Barr Virus Replication Proteins in Burkitt’s Lymphoma Cells
Tekijä: Chris Traylen, et al.
Julkaistu: (2015-10-01) -
Zebularine reactivates silenced <it>E-cadherin </it>but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells
Tekijä: Nadal David, et al.
Julkaistu: (2007-01-01)